enGene Therapeutics (ENGN) Net Long-Term Debt Issued (Repaid) (2023 - 2026)
enGene Therapeutics (ENGN) posted Non-Current Debt of $25.16 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 42.1% from $17.71 million a year earlier and up 1.0% from the prior quarter.
Powered by 
Analysis
enGene Therapeutics (ENGN) Net Long-Term Debt Issued (Repaid) (2023 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), enGene Therapeutics' Non-Current Debt came in at $15.32 million, down 31.8% from FY2024.
- Annual Non-Current Debt shows a three-year compound annual growth rate of 16.7% (FY2022 to FY2025).
- In prior fiscal years, enGene Therapeutics' Non-Current Debt was $22.47 million in FY2024 (+143.8%), $9.22 million in FY2023 (-4.5%) and $9.65 million in FY2022.
- The fiscal Q3 2026 figure stands as the highest quarterly Non-Current Debt in data going back to fiscal Q4 2022.
- On a year-over-year basis, Non-Current Debt has increased in each of the last three quarters, with growth averaging 19.9% over the last eight quarters.
- The strongest year-over-year quarter for Non-Current Debt in the past five years was fiscal Q4 2024, with growth of 143.8%; the weakest was fiscal Q4 2025, with a decline of 31.8%.
- According to Business Quant data, Non-Current Debt for the three prior fiscal quarters was $24.91 million (Q2 2026), $24.74 million (Q1 2026) and $15.32 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net LT Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | -1.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 9.98 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 4.91 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | -3.05 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | -19.00 Mn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | - |
| 10 | enGene Therapeutics | 161.50 Mn | -832.97 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jan 31, 2026 | 25.00 Mn |
| Jan 31, 2024 | 22.50 Mn |
| Jul 31, 2023 | 30.00 Mn |
API Access
enGene Therapeutics Net Long-Term Debt Issued (Repaid) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();